TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
-4.0%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.76 | +89.2% |
| 2024 | 0.40 | -34.0% |
| 2023 | 0.61 | -29.1% |
| 2022 | 0.86 | +2200.7% |
| 2021 | 0.04 | +121.5% |
| 2020 | -0.18 | -252.4% |
| 2019 | 0.11 | - |